The real estate innovator was (for a time) a five-bagger in 2025 before settling out at a 264% gain on the year.

Learn why ADMA Biologics looked undervalued near $2 in 2021—asset value, revenue growth, insider buying, and a path to profitability. Click here to read more.

Tesla's 2025 recalls covered more than 745,000 vehicles. Many of the issues were resolved with software updates. Here's a ...

A report by Oxford Economics, commissioned by the International Franchise Association, found the franchise model contributed ...

Slow compliance puts utilities ability to meet the emission targets in doubt and could drive up costs for ratepayers.

The Texans-Patriots rivalry has been one-sided in terms of the scoreboard but hasn't lacked for memorable moments through the ...

Former NFL offensive lineman Matt Kalil is reportedly suing his ex-wife, model Haley Kalil, after she alluded to the size of ...

The fashion industry’s extractive model, coupled with the throwaway attitudes it encourages, is driving the planet’s ...

Duolingo is leading the language learning app space through innovative marketing, creating an attractive growth story with strong user growth and earnings. Previous backlash regarding DUOL's AI ...

We explore five discontinued models that we predict will increase substantially in price in the near future due to their ...

"Reliability is why we bought it." Now, a 2021 Toyota Highlander owner is facing a total transmission failure at just 65,000 ...

It's a huge change to Tesla's approach with FSD, and it could impact Musk's $1T pay package and the company's myriad legal ...